欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5206/002
药品名称Meropenem 1g Powder for Solution for Injection or Infusion
活性成分
    • Meropenem trihydrate 1.0 g
剂型Powder for solution for injection/infusion
上市许可持有人Steriscience B.V. Kranenburgweg 135-A 2583 ER The Hague The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Slovenia (SI)
    • Belgium (BE)
    • Finland (FI)
    • Malta (MT)
    • Luxembourg (LU)
    • Poland (PL)
    • Croatia (HR)
    • Iceland (IS)
    • Latvia (LV)
    • Ireland (IE)
    • Lithuania (LT)
      -
    • Austria (AT)
    • Estonia (EE)
    • France (FR)
    • Hungary (HU)
    • Spain (ES)
    • Bulgaria (BG)
      Meropenem
    • Portugal (PT)
    • Cyprus (CY)
      MEROPENEM 1G POWDER FOR SOLUTION FOR INJECTION OR INFUSION
    • Italy (IT)
    • Czechia (CZ)
      MERONEM
    • Greece (GR)
    • Romania (RO)
    • Sweden (SE)
    • Slovakia (SK)
    • Denmark (DK)
      Meropenem Tenshi
    • Norway (NO)
许可日期2022/02/09
最近更新日期2025/01/14
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase